Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,347 | 43,915 | 195,579 | 55,516 | 37,185 |
| Marketable Securities | 880,093 | 898,348 | 767,397 | 306,563 | 339,056 |
| TOTAL | $936,649 | $945,724 | $966,335 | $367,225 | $381,300 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,239 | 1,115 | 1,183 | 1,265 | 1,363 |
| TOTAL | $1,239 | $1,115 | $1,183 | $1,265 | $1,363 |
| Total Assets | $937,888 | $946,839 | $967,518 | $368,490 | $382,663 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 254 | 11,090 | 5,225 | 7,512 | 5,711 |
| TOTAL | $25,685 | $25,093 | $32,774 | $19,135 | $13,405 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 755 | 766 | 852 | 936 | 1,018 |
| TOTAL | $755 | $766 | $852 | $936 | $1,018 |
| Total Liabilities | $26,440 | $25,859 | $33,626 | $20,071 | $14,423 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 111,436 | 110,796 | 110,268 | 100,488 | 100,029 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -452,490 | -427,550 | -405,299 | -377,944 | -353,339 |
| Other shareholders' equity | 1,632 | -2,272 | -1,599 | -184 | -700 |
| TOTAL | $911,448 | $920,980 | $933,892 | $348,419 | $368,240 |
| Total Liabilities And Equity | $937,888 | $946,839 | $967,518 | $368,490 | $382,663 |